🚀 VC round data is live in beta, check it out!
Vivesto Valuation Multiples
Discover revenue and EBITDA valuation multiples for Vivesto and similar public comparables like Genxone, MetaVia, RA Williams Distributors, ExpreS2ion Biotech and more.
Vivesto Overview
About Vivesto
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
Founded
1988
HQ
Employees
18
Website
Sectors
Financials (LTM)
EV
$5M
Vivesto Financials
Vivesto reported last 12-month revenue of — and negative EBITDA of ($4M).
In the same LTM period, Vivesto generated — in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
Revenue (LTM)
Vivesto P&L
In the most recent fiscal year, Vivesto reported revenue of — and EBITDA of ($3M).
Vivesto expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | ($4M) | XXX | ($3M) | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Vivesto Stock Performance
Vivesto has current market cap of $5M, and enterprise value of $5M.
Market Cap Evolution
Vivesto's stock price is $0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $5M | -1.1% | XXX | XXX | XXX | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialVivesto Valuation Multiples
Vivesto trades at (1.5x) EV/EBITDA.
EV / Revenue (LTM)
Vivesto Financial Valuation Multiples
As of March 28, 2026, Vivesto has market cap of $5M and EV of $5M.
Equity research analysts estimate Vivesto's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Vivesto has a P/E ratio of (1.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV/EBITDA | (1.5x) | XXX | (1.6x) | XXX | XXX | XXX |
| EV/EBIT | (1.4x) | XXX | (1.4x) | XXX | XXX | XXX |
| P/E | (1.5x) | XXX | (1.5x) | XXX | XXX | XXX |
| EV/FCF | (1.2x) | XXX | (1.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Vivesto Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Vivesto Margins & Growth Rates
Vivesto's revenue in the last fiscal year grew by —.
Vivesto's revenue per employee in the last FY averaged $0.0M.
Vivesto Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | 3% | XXX | (4%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Vivesto Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Genxone | XXX | XXX | XXX | XXX | XXX | XXX |
| MetaVia | XXX | XXX | XXX | XXX | XXX | XXX |
| RA Williams Distributors | XXX | XXX | XXX | XXX | XXX | XXX |
| ExpreS2ion Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Institute of Biomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Vivesto M&A Activity
Vivesto acquired XXX companies to date.
Last acquisition by Vivesto was on XXXXXXXX, XXXXX. Vivesto acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Vivesto
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialVivesto Investment Activity
Vivesto invested in XXX companies to date.
Vivesto made its latest investment on XXXXXXXX, XXXXX. Vivesto invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Vivesto
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Vivesto
| When was Vivesto founded? | Vivesto was founded in 1988. |
| Where is Vivesto headquartered? | Vivesto is headquartered in Sweden. |
| How many employees does Vivesto have? | As of today, Vivesto has over 18 employees. |
| Who is the CEO of Vivesto? | Vivesto's CEO is Erik Kinnman. |
| Is Vivesto publicly listed? | Yes, Vivesto is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Vivesto? | Vivesto trades under VIVE ticker. |
| When did Vivesto go public? | Vivesto went public in 2005. |
| Who are competitors of Vivesto? | Vivesto main competitors are Genxone, MetaVia, RA Williams Distributors, ExpreS2ion Biotech. |
| What is the current market cap of Vivesto? | Vivesto's current market cap is $5M. |
| Is Vivesto profitable? | No, Vivesto is not profitable. |
| What is the current EBITDA of Vivesto? | Vivesto has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of Vivesto? | Current EBITDA multiple of Vivesto is (1.5x). |
| What is the current FCF of Vivesto? | Vivesto's last 12 months FCF is ($5M). |
| What is the current EV/FCF multiple of Vivesto? | Current FCF multiple of Vivesto is (1.2x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.